A company with growing sales.
Facts from SEC filings, not a recommendation.
From CBRS's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
Last 12 months: $576.4M.
Move the sliders to your own view of CBRS. Starting points are the company's recent numbers (it isn't profitable yet, so the margin starts at a 10% guess).
What today's price needs: with a 10% margin and a 15x P/E, sales would have to grow about 80% a year for 5 years just to match today's price.
Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.
Price chart by TradingView.
50 is neutral. Buying by more insiders, top executives and bigger stakes raises it. Selling lowers it; pre-planned sales count less.
SEC filings of any kind. 50 means a normal week.
Institutions held almost none of it the quarter before (new listing, spin-off or ticker change), so there's no fair percent change yet. 404 bought, 0 sold.
| Insider | Trade | Shares | Avg price | Value | Owns after | Date |
|---|---|---|---|---|---|---|
Robert Patrick Jr. KominChief Financial Officer | Sell | 33K | $203.53 | $6.6M | 0 | Sep 29Filing ↗ |
| ||||||
Dhiraj MallickChief Operating Officer | Sell | 396K | $204.04 | $80.8M | 0 | Sep 29Filing ↗ |
| ||||||
Yagnesh PatelChief Accounting Officer | Sell | 1K | $204.50 | $270K | 15K | Sep 28Filing ↗ |
| ||||||
Sean LieChief Technology Officer | Sell | 120K | $208.97 | $25.1M | 310K | Sep 25Filing ↗ |
| ||||||
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
59,126 shares
159 shares
1,329,973 shares
1,320 shares at $204.50 · $270K
396,000 shares at $204.04 avg ($194.91 to $212.93) · $80.8M
32,500 shares at $203.53 avg ($194.92 to $211.79) · $6.6M
Source: SEC EDGAR filings. For informational purposes. Not investment advice.
Report a problem with this page